0001232524-18-000032.txt : 20180228
0001232524-18-000032.hdr.sgml : 20180228
20180228175718
ACCESSION NUMBER: 0001232524-18-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180226
FILED AS OF DATE: 20180228
DATE AS OF CHANGE: 20180228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Matthew P.
CENTRAL INDEX KEY: 0001601583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 18653248
MAIL ADDRESS:
STREET 1: C/O JAZZ PHARMACEUTICALS PLC
STREET 2: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD
CITY: DUBLIN L2 4
STATE: L2
ZIP: 0
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-02-26
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001601583
Young Matthew P.
5TH FL, WATERLOO EXCHANGE
WATERLOO RD
DUBLIN 4
L2
IRELAND
0
1
0
0
EVP & CFO
Ordinary Shares
2018-02-26
4
F
0
2253
147.44
D
36706
D
Ordinary Shares
2018-02-27
4
S
0
1016
144.961
D
35690
D
Ordinary Shares
2018-02-27
4
S
0
600
145.8333
D
35090
D
Ordinary Shares
2018-02-27
4
S
0
300
147.2967
D
34790
D
Ordinary Shares
2018-02-27
4
F
0
606
143.8
D
34184
D
Ordinary Shares
2018-02-28
4
S
0
200
145.245
D
33984
D
Ordinary Shares
2018-02-28
4
S
0
119
147.5561
D
33865
D
Ordinary Shares
2018-02-28
4
S
0
200
149.015
D
33665
D
Ordinary Shares
2018-02-28
4
S
0
700
150.0
D
32965
D
Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.3100 to $145.2600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.4300 to $146.2700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.0600 to $147.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.0500 to $145.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.2200 to $147.6200. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.6200 to $149.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
By: /s/Peter A Christou, as attorney in fact For: Matthew Paul Young
2018-02-28